On Nov. 10, 2015, Mr. Huber lost his wife to colon cancer. He is now going to be the CEO of the startup Grail, which will focus on the development of an early detection blood test for cancer.
The company, created by genetic variation and biological function analysis company Illumina, is backed by funding from its founder, Sutter Hill Ventures, ARCH Ventures, Bezos Expeditions and Bill Gates, according to the report.
Grail has already raised $100 million.
More articles on health IT:
The CIO’s role in cost improvement
Federal government seeking first-ever CISO
Walgreens introduces drug disposal kiosks at 500 stores
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
